System and method for dual energy and/or contrast enhanced breast imaging for screening, diagnosis and biopsy

US12239471B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12239471-B2
Application numberUS-202217843417-A
CountryUS
Kind codeB2
Filing dateJun 17, 2022
Priority dateMar 8, 2011
Publication dateMar 4, 2025
Grant dateMar 4, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods for x-ray imaging a patient's breast in combinations of dual-energy, single-energy, mammography and tomosynthesis modes that facilitate screening for and diagnosis of breast abnormalities, particularly breast abnormalities characterized by abnormal vascularity.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for imaging a breast of a patient, the method comprising: injecting a contrast agent into the patient; immobilizing, between an x-ray source and an x-ray detector of an imaging system, the breast of the patient; performing a 2D imaging procedure on the breast of the patient, the 2D imaging procedure being based on dual energy exposures; generating at least a low energy image obtained at an energy below a k-edge of the contrast agent and a high energy image obtained at an energy above the k-edge of the contrast agent; processing a dual energy subtraction image from the low energy image and the high energy image, wherein the dual energy subtraction image enhances visualization of abnormalities, the abnormalities characterized by highlighted vascularity of breast tissue under contrast; displaying at least the dual energy subtraction image on a display of the imaging system; identifying at least one abnormality within at least the dual energy subtraction image; performing a single energy 3D imaging procedure on the breast of the patient; generating a plurality of slice images of the breast of the patient; reconstructing a plurality of projection images from the plurality of slice images; identifying a subset of the plurality of projection images that the at least one abnormality appears in; and displaying one or more of the subset of the plurality of projection images along with the dual energy subtraction image on the display. 2. The method of claim 1 , wherein the 2D imaging procedure is a craniocaudal or a mediolateral oblique orientation procedure. 3. The method of claim 1 , wherein the contrast agent is iodine-based. 4. The method of claim 1 , wherein the x-ray source includes at least two filters, and wherein the 2D imaging procedure includes changing between a first filter and a second filter between the dual energy exposures. 5. The method of claim 1 , wherein injecting the contrast agent into the patient occurs one or two minutes prior to immobilizing the breast of the patient. 6. The method of claim 1 , further comprising processing one or both of the low energy image and the high energy image prior to processing the dual energy subtraction image. 7. The method of claim 1 , further comprising displaying the low energy image and the dual energy subtraction image on the display of the imaging system. 8. The method of claim 7 , wherein displaying the low energy image and the dual energy subtraction image on the display of the imaging system includes displaying side by side or toggling the low energy image with the dual energy subtraction image. 9. The method of claim 1 , wherein the single energy imaging procedure has an x-ray energy that is different than the energy of the low energy image and the energy of the high energy image. 10. An imaging system for imaging a breast of a patient with an injected contrast agent, the system comprising: an x-ray source; an x-ray detector; a compression mechanism disposed between the x-ray source and the x-ray detector; a display; and a control module programmed with a set of instructions that when executed cause the imaging system to perform a set of operations, comprising: immobilizing, via the compression mechanism, the breast of the patient; performing a 2D imaging procedure on the breast of the patient, the 2D imaging procedure being based on dual energy exposures; generating at least a low energy image obtained at an energy below a k-edge of the contrast agent and a high energy image obtained at an energy above the k-edge of the contrast agent; processing a dual energy subtraction image from the low energy image and the high energy image, wherein the dual energy subtraction image enhances visualization of abnormalities, the abnormalities characterized by highlighted vascularity of breast tissue under contrast; displaying the dual energy subtraction image on the display; identifying at least one abnormality within at least the dual energy subtraction image; performing a single energy 3D imaging procedure on the breast of the patient; generating a plurality of slice images of the breast of the patient; reconstructing a plurality of projection images from the plurality of slice images; identifying a subset of the plurality of projection images that the at least one identifiable abnormality appears in; and displaying one or more of the subset of the plurality of projection images along with the dual energy subtraction image on the display. 11. The imaging system of claim 10 , wherein the 2D imaging procedure is a craniocaudal or a mediolateral oblique orientation procedure for at least the x-ray source. 12. The imaging system of claim 10 , wherein the contrast agent is iodine-based. 13. The imaging system of claim 10 , wherein the x-ray source includes at least two filters. 14. The imaging system of claim 10 , wherein the set of operations the control module performs further includes processing one or both of the low energy image and the high energy image prior to processing the dual energy subtraction image. 15. The imaging system of claim 10 , wherein the set of operations the control module performs further includes displaying the low energy image and the dual energy subtraction image on the display. 16. The imaging system of claim 15 , wherein displaying the low energy image and the dual energy subtraction image on the display includes displaying side by side or toggling the low energy image with the dual energy subtraction image. 17. The imaging system of claim 10 , wherein the single energy imaging procedure has an x-ray energy that is different than the energy of the low energy image and the energy of the high energy image.

Assignees

Inventors

Classifications

  • involving multiple energy imaging · CPC title

  • combining images from the same or different ionising radiation imaging techniques, e.g. PET and CT · CPC title

  • for diagnosis of breast, i.e. mammography · CPC title

  • involving the use of contrast agents · CPC title

  • characterised by displaying multiple images or images and diagnostic data on one display · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12239471B2 cover?
Systems and methods for x-ray imaging a patient's breast in combinations of dual-energy, single-energy, mammography and tomosynthesis modes that facilitate screening for and diagnosis of breast abnormalities, particularly breast abnormalities characterized by abnormal vascularity.
Who is the assignee on this patent?
Hologic Inc
What technology area does this patent fall under?
Primary CPC classification A61B6/025. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).